How Starbucks Managed to Wow Investors on the Bottom Line
Starbucks reported a net loss of $0.46 per share and $4.2 billion in revenue for its fiscal third quarter, compared with consensus estimates that called for a net loss of $0.59 per share and…
All Work
Chris Lange
Great News for Lung Cancer Patients in Spectrum’s Phase 2 Trial
Spectrum Pharmaceuticals announced good news for lung cancer patients in its midstage trial on Tuesday.
Rocket Companies Gears Up for IPO
Personal finance and consumer service firm Rocket Companies has filed with the SEC for its initial public offering.
Altria Q2 Earnings Are Smoking
Altria reported better than expected quarterly results and re-established its 2020 full-year earnings guidance before the markets opened on Tuesday.
COVID-19 Hopes Weren’t the Only Thing Driving Pfizer in Q2
Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.
Are 3M Sales Really Improving?
3M released disappointing second-quarter financial results before the markets opened on Tuesday
Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step
Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead mRNA vaccine candidate.
Cannabis SPAC Lined Up to Come Public
Schultze Special Purpose Acquisition has announced that it will combine with Clever Leaves International to operate under the name Clever Leaves.
MediciNova Is the Newest COVID-19 Stock
MediciNova saw the coronavirus bump on Monday after it said it had entered a worldwide exclusive agreement with BioComo for the rights to develop a SARS-CoV-2 vaccine.
Rackspace Technology Gears Up to Come Public
Technology services company Rackspace intends to price more than 33 million shares to result in an initial public offering valued at over $924 million.
Meet the Newest Online Casino SPAC
dMY Technology Group is bringing the online casino and sports wagering firm Rush Street Interactive public, joining the list of online gaming stocks.
Big Biotechs Scare Off Short Sellers
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Short Sellers Can’t Make Up Their Minds on Semiconductors
The July 15 short interest data have been compared with the previous report. Short interest moves these selected semiconductor stocks were mixed.
Altria, Ford, GE, Starbucks and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including Altria, Ford, General Electric and Starbucks
Apple, Boeing, Exxon, McDonald’s, Visa and More Dow Earnings This Week
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Apple, Boeing, Exxon, McDonald's and Visa.
Alphabet, Amazon, Facebook and More Tech/Media Earnings Coming This Week
24/7 Wall St. has put together a preview of some of the larger tech companies that are about to report their quarterly results, including Alphabet, Amazon and Facebook.
AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Will the Credits Roll for AMC After This Reopening Delay?
Summer blockbusters may have to wait a little longer to hit theaters now that the world’s largest movie-theater chain announced that it would further delay its reopening.
Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling
Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute that could have implications for coronavirus vaccine frontrunner Moderna.
Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.